lyophilization pharmaceutical products - An Overview
This tends to support establish the boundary problems with the CIN process parameters to attain the desired process/product performance. After the modest-scale ranges are described, CIN cycles could possibly be executed in the manufacturing scale to determine the CIN parameter robustness at scale.Protein formulation and lyophilization cycle design: